In conclusion, preoperative albumin (the cutoff is 41.9 g/L) is may help stratify DVT risk in intermediate-risk non-cardiac surgical patients, though prospective validation is needed given study limitations. The gene discussed is ALB; the disease is deep vein thrombosis.